Results 221 to 230 of about 3,471,024 (333)

On Simple Acute Inflammation of the Membranes of the Brain in Infants [PDF]

Rilliet
openalex   +3 more sources

Anti-Atherogenic Mechanisms and Therapies. [PDF]

Curr Atheroscler Rep
Hudson A, Igiehon OO, Woolard MD, Yurdagul A.   +3 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Alpha-bisabolol protects against neonatal asthma by suppressing airway inflammatory signaling. [PDF]

Int J Med Sci
Thiruvengadam R, Govindarasu M, Khaled JMA, Lee S, Kim JH.   +4 more
europepmc   +1 more source

On inflammation and abscess of the uterine appendages [PDF]

Fleetwood Churchill
openalex   +1 more source

On the Relation of Epithelioma to Irritation and Chronic Inflammation [PDF]

, 1881
F. S. Eve
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Prognostic nutritional index is a better inflammation based prognostic marker in elderly patients with hepatocellular carcinoma after surgery. [PDF]

Sci Rep
Wu Q, Zeng J, Zeng J.
europepmc   +1 more source

Investigations into the nature of jequirity inflammations [PDF]

, 1884
Arthur H. Benson
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source